Cox, Kristin E.
Turner, Michael A.
Lwin, Thinzar M.
Amirfakhri, Siamak
Kelly, Kaitlyn J.
Hosseini, Mojgan
Ghosh, Pradipta
Obonyo, Marygorret
Hoffman, Robert M.
Yazaki, Paul J.
Bouvet, Michael http://orcid.org/0000-0002-0086-2159
Funding for this research was provided by:
Department of Defense (W81XWH-20-1-0675)
VA Merit Review (1 I01 BX003856-01A1, 1 I01 BX004494-01)
Padres Pedal the Cause Collaborative Translational Pilot Project (PTC2021, PTC2022)
National Institutes of Health (R01 CA100768, R01 CA238042, R01 CA256973-01, T32 CA121938)
Torrey Coast Foundation
National Cancer Institute (CCSG Grant P30CA23100)
Article History
Received: 2 April 2024
Accepted: 21 May 2024
First Online: 18 June 2024
Disclosure
: RMH is a non-salaried affiliate of Anti Cancer, Inc. which produces patient-derived orthotopic xenograft (PDOX) mouse models for contract research. PY declares a patent covering anti-CEA M5A antibody for fluorescence guided surgery.